These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4073791)

  • 1. Low serum magnesium concentration in Paget's disease of bone (osteitis deformans).
    Taylor WH
    Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():591-5. PubMed ID: 4073791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R; Eisinger J; Recordier AM
    Rhumatologie; 1971 Apr; 23(4):119-39. PubMed ID: 4254981
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone.
    Avioli LV; Berman M
    J Clin Endocrinol Metab; 1968 May; 28(5):700-10. PubMed ID: 5653203
    [No Abstract]   [Full Text] [Related]  

  • 7. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A; Valverde C; Tap G; Bazerque JJ; Ayrolles C
    Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2-Microglobulin in Paget's bone disease.
    Rico H; Ripoll E; Arribas I; Revilla M; Relea P; Villa LF; de Buergo MA
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment of Paget's disease of bone with synthetic human calcitonin.
    Lang R; Milkman M; Jensen PS; Vignery AM
    Yale J Biol Med; 1981; 54(5):355-65. PubMed ID: 7336766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP; Gertz BJ; Tindale W; Sciberras DG; Survill TT; Kanis JA
    J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical measurements in Paget's disease of bone.
    Russell RG; Colwell A; Hannon RA; Blumsohn A; al-Dehaimi AW; Assiri AM; Peel NF; Eastell R
    Semin Arthritis Rheum; 1994 Feb; 23(4):240-1. PubMed ID: 8009238
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
    Kanis JA; Fitzpatrick K; Strong JA
    Q J Med; 1975 Jul; 44(175):399-413. PubMed ID: 1101286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
    Bower L; Manley G
    J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA; Preston CJ; Couch M; Kanis JA
    Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.